Lily Chu

Lily Chu, MD, MSHS, is board certified in both internal medicine and geriatric medicine.

Education

 * Geriatric Medicine Fellowship, University of California, Los Angeles


 * MSHS, Public Health, University of California, Los Angeles
 * Internal Medicine Residency, University of Rochester
 * MD, University of Washington
 * BS, Biology, University of Washington

Boards and Committees

 * Community Advisory Board Member at Stanford University Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Initiative


 * Co-Vice president of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis


 * Panel member of the 2015 Institute of Medicine report: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness

ME/CFS Common Data Elements (CDE) Project
Dr Chu is Co-chair of Post-exertional Malaise Working Group and a member of the Sleep Working Group and the Biomarkers Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Elements (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.

Quotes

 * 2016, "Ultimately the best way to prevent suicide in ME/CFS will be to find effective disease-modifying treatments or cures for it."

Publications

 * 2012, "Exercise and chronic fatigue syndrome: maximize function, minimize post-exertional malaise," Letter to the Editor, European Journal of Clinical Investigation
 * Preliminary Results – April 2013 FDA Workshop Survey, By Lily Chu, Leonard Jason, Madison Sunnquist, and Suzanna So
 * May 2016, [http:http://iacfsme.org/PDFS/2016MayNesletter/Attachment-03-Dr-Lily-Chu-ME-CFS-and-suicide.aspx Suicide and ME/CFS -- Lily Chu, MD, MSHS]
 * 2017, Article commentary - Differences of opinion on systemic exercise intolerance disease are not ‘mistakes’: a rejoinder to Jason Sunnquist, Gleason and Fox

Open Letter to The Lancet
Three open letters to the editor of The Lancet have been sent urging the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Chu, along with 41 colleagues in the ME/CFS field, signed the second letter.
 * 10 February 2016, An open letter to The Lancet, again - Virology blog

Notable studies

 * 2021, Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - (Full text)


 * 2021, Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (Full text)


 * 2020, Environmental accommodations for university students affected by myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) - (Full text)


 * 2019, Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome (Full text)


 * 2018, Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey (Full Text)


 * 2017, Cytokine signature associated with disease severity in chronic fatigue syndrome patients (Full Text)


 * 2017, Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria


 * 2013, Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology (Full Text)

Talks and interviews

 * 2015, Solve CFS Webinar - Post-Exertional Malaise: History, Characteristics, Evidence
 * Written questions and answers to Dr. Chu's webinar

HHS/CFSAC Testimony

 * CFSAC Public Testimony December 2014
 * Written Testimony for June 2012 meeting
 * Written Testimony for Nov 2011 meeting
 * Written Testimony for May 2011 meeting
 * Written Testimony for October 2009 meeting

Online presence

 * Twitter
 * Facebook
 * LinkedIn
 * Youtube
 * Website